Directional atherectomy combined with drug-coated balloon angioplasty for superficial femoral arteriosclerosis obliterans
The Annals of The Royal College of Surgeons of England · 2023
DOI: 10.1308/rcsann.2022.0164 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Annals of The Royal College of Surgeons of England, 2023. Verfasst von Z Su und 5 weiteren Autor:innen. Beteiligte Einrichtung: Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Arteriosclerosis Obliterans, Vascular Access Devices, Angioplasty, Balloon. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
This study is an analysis of the therapeutic effects of directional atherectomy combined with drug-coated balloon angioplasty (DA+DCB) in treating superficial femoral arteriosclerosis obliterans.
Methods
Patients in our hospital with superficial femoral arteriosclerosis obliterans who received DA+DCB during the period June 2016 to February 2019 were identified retrospectively. Preoperative demographics, operative details and postoperative follow-up outcomes were analysed statistically.
Results
Between June 2016 and February 2019, 48 patients were enrolled in this retrospective study. The average age of the patients was 66.85 ± 11.28 years; 83.3% of the patients were male. During the procedure, flow-limiting dissection occurred frequently (9/48 patients) and there were six bailout stent implantations owing to flow-limiting dissections. The incidence rate of target artery thrombosis was 4.2% (2/48). There was no vessel perforation, embolism or operation-related death. The technical success rate was estimated at 100%. The mean ankle–brachial index of the patients was 0.54 ± 0.28 before the operation and 0.93 ± 0.13 before discharge (p < 0.0001). The mean follow-up time was 19.6 ± 9.0 months. The primary patency rate was 89.4%, 82.4% and 76.5% at 12, 24 and 36 months. The freedom from target lesion revascularisation (TLR) was 97.9%, 93.8% and 84.4% at 12, 24 and 36 months.
Conclusion
The use of DA+DCB showed good clinical benefit for superficial femoral arteriosclerosis obliterans, which had good primary patency and freedom from TLR. Multicentre randomised controlled trials with long-term follow-up are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xuanwu Hospital, Capital Medical University, Beijing, China.
Zitieren
APA
Su, Z., Li, Y., Wang, C., Guo, J., Guo, L., & Gu, Y. (2023). Directional atherectomy combined with drug-coated balloon angioplasty for superficial femoral arteriosclerosis obliterans. The Annals of The Royal College of Surgeons of England. https://doi.org/10.1308/rcsann.2022.0164
Vancouver
Su Z, Li Y, Wang C, Guo J, Guo L, Gu Y. Directional atherectomy combined with drug-coated balloon angioplasty for superficial femoral arteriosclerosis obliterans. The Annals of The Royal College of Surgeons of England. 2023. doi:10.1308/rcsann.2022.0164
BibTeX
@article{Su2023,
author = {Su, Z and Li, Y and Wang, C and Guo, J and Guo, L and Gu, Y},
title = {Directional atherectomy combined with drug-coated balloon angioplasty for superficial femoral arteriosclerosis obliterans},
journal = {The Annals of The Royal College of Surgeons of England},
year = {2023},
doi = {10.1308/rcsann.2022.0164}
}
EUVIMED